In this 1.5 hour intermediate to advanced discussion of setting OELs including selection of points of departure, selection of adjustment factors, pharmacokinetic variability (including bioavailability), interspecies adjustment, and what to do with limited data sets. We will focus on exposure to pharmaceutical compounds and will discuss how the data should be interpreted and applies specifically for occupational scenarios. Sample data sets and compound-specific examples will be reviewed.Who Should Attend
The webinars will be led by Bob Sussman, Ph.D., DABT, Tracy Kimmel, Ph.D., DABT and Elizabeth Vancza, Ph.D., DABT, SDSRP of SafeBridge Consultants, Inc., the premier occupational health and safety consulting firm to the bio- and pharmaceutical industries, especially with regard to potent compounds. Each pharmaceutical occupational toxicology and industrial hygiene experience in the systematic and scientific approach to safe handling of potent active pharmaceutical ingredients and drug products.
Note: The course fee is per attendee. Recording the training course is strictly prohibited.
For registration questions please contact Kent Rader at Kent.Rader@safebridge.com